Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
September 29, 2009
Pre-operative determination of an individual's neutrophil response: a potential predictor of early cardiac transplant cellular rejection
Alan Soo, Belinda Maher, James McCarthy, et al.
Cells
|
February 25, 2022
High Throughput Screening Targeting the Dengue NS3-NS5 Interface Identifies Antivirals against Dengue, Zika and West Nile Viruses
Sundy N Y Yang, Belinda Maher, Chunxiao Wang, et al.
RSC Medicinal Chemistry
|
April 25, 2025
VHL-independent degradation of hepatitis B virus e antigen (HBeAg) by VHL-binding chimeric small molecules
Liam T Hales, Simon J Mountford, Mina Takawy, et al.
Ejhaem
|
August 21, 2025
Dynamic Profiling of Cell Free Tumour DNA in Aggressive B-Cell Lymphoma From Diagnosis to Transformation at Relapse
Mark Waltham, Jonathan Wong, Galina Polekhina, et al.
Cells
|
March 27, 2019
Novel Flavivirus Antiviral That Targets the Host Nuclear Transport Importin α/β1 Heterodimer
Sundy N Y Yang, Sarah C Atkinson, Johanna E Fraser, et al.
The FEBS Journal
|
July 8, 2024
Mapping the IMiD-dependent cereblon interactome using BioID-proximity labelling
Matteo Costacurta, Jarrod J Sandow, Belinda Maher, et al.
The Journal of Infectious Diseases
|
June 7, 2014
A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection
Johanna E Fraser, Satoru Watanabe, Chunxiao Wang, et al.
Communications Medicine
|
April 26, 2025
Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus
Baolong Pan, Simon J Mountford, Maki Kiso, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 29, 2023
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphoma
Danielle H Oh, Xiao Ma, Simon J Hogg, et al.
Molecular Cancer Therapeutics
|
November 4, 2025
Discovery and characterisation of VPRBP/DCAF1 kinase inhibitor analogues as microtubular destabilising agents with potent anti-myeloma activity
Olivia Susanto, Emily Gruber, Cheng Mun Wun, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
September 29, 2009
Pre-operative determination of an individual's neutrophil response: a potential predictor of early cardiac transplant cellular rejection
Alan Soo, Belinda Maher, James McCarthy, et al.
Cells
|
February 25, 2022
High Throughput Screening Targeting the Dengue NS3-NS5 Interface Identifies Antivirals against Dengue, Zika and West Nile Viruses
Sundy N Y Yang, Belinda Maher, Chunxiao Wang, et al.
RSC Medicinal Chemistry
|
April 25, 2025
VHL-independent degradation of hepatitis B virus e antigen (HBeAg) by VHL-binding chimeric small molecules
Liam T Hales, Simon J Mountford, Mina Takawy, et al.
Ejhaem
|
August 21, 2025
Dynamic Profiling of Cell Free Tumour DNA in Aggressive B-Cell Lymphoma From Diagnosis to Transformation at Relapse
Mark Waltham, Jonathan Wong, Galina Polekhina, et al.
Cells
|
March 27, 2019
Novel Flavivirus Antiviral That Targets the Host Nuclear Transport Importin α/β1 Heterodimer
Sundy N Y Yang, Sarah C Atkinson, Johanna E Fraser, et al.
The FEBS Journal
|
July 8, 2024
Mapping the IMiD-dependent cereblon interactome using BioID-proximity labelling
Matteo Costacurta, Jarrod J Sandow, Belinda Maher, et al.
The Journal of Infectious Diseases
|
June 7, 2014
A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection
Johanna E Fraser, Satoru Watanabe, Chunxiao Wang, et al.
Communications Medicine
|
April 26, 2025
Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus
Baolong Pan, Simon J Mountford, Maki Kiso, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 29, 2023
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphoma
Danielle H Oh, Xiao Ma, Simon J Hogg, et al.
Molecular Cancer Therapeutics
|
November 4, 2025
Discovery and characterisation of VPRBP/DCAF1 kinase inhibitor analogues as microtubular destabilising agents with potent anti-myeloma activity
Olivia Susanto, Emily Gruber, Cheng Mun Wun, et al.
Page
of 2